Spring direct naar de hoofdnavigatie of de inhoud
‘Investing that little extra time and effort in IP at the right moment makes your technology go further.’
Jennifer Ebner von Eschenbach

Jennifer Ebner von Eschenbach

  • Chemistry
  • Life Sciences
  • European Patent Attorney
  • Senior Associate

Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

Continue reading

Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients.

Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

Working experience

  • Patent Attorney, V.O. (2008-present)
  • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
  • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)

Education

  • PhD in Chemistry, University of Melbourne (1988)
  • MSc in Chemistry, University of Melbourne (1984, with honours)

Directories

  • Jennifer Ebner von Eschenbach “offers clients extensive expertise in European patent prosecution and examination proceedings, advising on portfolio structuring and filing strategies to support robust and defensible patent protection before the EPO” (IAM Patent 1000, 2026)
  • “Focusing her practice on the pharmaceutical and chemistry sectors, Jennifer Ebner von Eschenbach is a savvy strategist with three decades of wisdom up her sleeve. She adeptly navigates the prosecution landscape to ensure all areas of her patrons’ innovations are robustly protected” (IAM Patent 1000, 2024, 2025)
  • “Chemistry expert Jennifer Ebner von Eschenbach gives added heft to the firm’s life science specialisation. Detail oriented and strategic, she delivers commercially astute and technically deft prosecution to her following. With over three decades of experience in the profession, Ebner is a smart choice for business-critical portfolios across a wide array of chemical and pharmaceutical innovations” (IAM Patent 1000, 2023)
  • Recommended Individual (IAM Patent 1000, 2023 – 2026)

Publications

  • •Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
  • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
  • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
  • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988

Languages

  • German
  • English

Also see these experts

Kristel Van den Broeck

Kristel Van den Broeck

  • European Patent Attorney
  • Senior Associate
Otto Oudshoorn

Otto Oudshoorn

  • European and Dutch Patent Attorney, European Patent Litigator
  • Partner
More experts

News

The license of right for the unitary patent: smart cost saving or strategic limitation?

With the introduction of the European patent with unitary effect (unitary patent or UP), patent holders now have access to new strategic tools. One of these is the license of right (LoR). What does such a declaration entail, and what advantages and disadvantages can it have for the protection of your intellectual property?Continue reading

UPC jurisdiction over UK designations and conditional infringement relief in Fujifilm v Kodak

In the case of Kodak vs. Fujifilm concerning EP 3 511 174 on 2 June 2026 before the Court of Appeal of the Unified Patent, the Court of Appeal addressed the UPC’s jurisdiction over the UK designation of a European patent. The decision is important because it applies the CJEU’s reasoning in BSH v Electrolux […]Continue reading

Case Law Clarity

Visitors to the V.O. website may already have noticed that it has recently been expanded with a new section: Case Law Clarity. With this addition, the website responds to the growing need for clear and consistent explanations of complex legal developments in patent law.Continue reading